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Introduction
Does it matter which hemodynamic monitoring system is 
used? While the question may sound simple, the answer 
is actually far from being clear. Th e purpose of a 
monitoring system is not to treat, but rather to provide 
clinical information that may impact medical decision-
making. To quote Michael Pinsky and Didier Payen: 
‘Finally, no monitoring tool, no matter how accurate, by 
itself has improved patient outcome’ [1]. If we were 
discussing a medication and asking the question ‘Does it 
matter which drug is used?’, the obvious answer would be 
‘Of course it matters! We should use the drug that has 
demonstrated the best positive impact on patients’ 
outcome in large randomized controlled trials, the least 
side eff ects, and the best price’. Th is would be a 
straightforward question with a straightforward answer. 
So why does the same question lead to so much confusion 
when it refers to hemodynamic monitoring systems?
Hemodynamic monitoring systems are measurement 
tools and their eff ects on outcomes are only as good as 
the protocols they are used to drive. Hemodynamic 
monitoring in the critical care setting and in the 
perioperative period has been studied for decades and 
has generated a still increasing number of publications. It 
is probably one of the most frequently featured topics in 
scientifi c journals and meetings, and one of the most 
popular focuses for symposiums. During the past 50 
years we have observed dramatic changes in technologies 
available for hemodynamic monitoring, ranging from 
very invasive to mini-invasive and eventually totally non-
invasive technologies [2-4]. At the same time, we have 
observed a conceptual shift in philosophy from the 
monitoring of static parameters to functional and 
dynamic approaches of hemodynamics [5]. Despite all 
these changes and ‘improvements’, it is still unclear 
whether or not it matters which hemodynamic monitor-
ing system we use in clinical practice. We will see that the 
answer to this question may actually be context depen-
dent [6-8]. Th e outcome most probably depends on the 
clinical setting (emergency department, operating room 
or ICU), on the hemodynamic situation the clinician tries 
to solve, and partially on the institution, the country and 
on the healthcare system where the clinician is practicing. 
Of course, it also depends on the protocol the clinician 
aims to apply to his or her patient and on the specifi c goal 
he or she wants to target (touching on the concept of 
goal-directed therapy [8-10]).
Eventually, the question remains as to how a hemo-
dynamic monitoring system should be evaluated. Of 
course, evaluating the impact on patient outcome should 
be the most important factor [11]. However, can we 
reasonably expect a hemodynamic monitoring system to 
improve patient outcome in the critical care setting? For 
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instance, the pulse oximeter, which has been evalu ated in 
randomized controlled trials conducted in more than 
20,000 patients in the anesthesiology setting, has never 
been shown to improve patient outcome [12,13]. In the 
same vein, there is no large randomized controlled trial 
showing that transesophageal echocardiography can 
improve patient survival even in the cardiac surgery 
setting [14]. Do we interpret this to mean that these 
devices should not be used in the clinical setting?
A few studies, especially in the perioperative period, 
have suggested that hemodynamic monitoring systems 
coupled with treatment protocols can improve patient 
outcome. Th ese trials are small and, overall, the corpus of 
science related to this topic does not yet fi t the standard 
of clinical research methodology encountered in other 
specialties such as cardiology and oncology. Larger 
randomized trials, quality improvement processes, and 
comparative eff ectiveness research studies will probably 
answer questions related to the real impact of these 
systems.
Th e term hemodynamic monitoring system is very 
broad and many concepts could be included under this 
terminology. Th e defi nition could range from micro-
circu lation and mitochondrial function monitoring to 
arterial pressure and heart rate monitoring. In the 
present article, we will focus our discussion on systems 
monitoring cardiac output (CO) and functional hemo-
dynamic parameters. Several review articles have been 
published recently detailing the diff erent hemo dynamic 
monitoring systems available, and we refer the readers to 
these manuscripts for an in-depth technological under-
standing of these systems [3,4,8,15].
Th e present paper is divided into three parts. In the 
fi rst part we will describe the evolution of hemodynamic 
monitoring in the critical care environment during the 
past 50 years (from the pulmonary artery catheter (PAC) 
to the most recent functional hemodynamic monitoring). 
In the second part, we will analyze how these systems 
have been evaluated in the clinical practice (accuracy for 
CO monitors and predictive value for functional hemo-
dynamic parameters) and we will analyze the impact of 
these systems on patient outcome. Lastly, in the third 
section, we propose a plan for the use of hemodynamic 
monitoring systems in critical care settings based on the 
specifi c clinical situation, the protocol to be applied, and 
on the patient. Th is approach is based on the model of 
clinical pathways and quality improvement processes 
implementation.
Hemodynamic monitoring in the critical care 
setting: from past to present
Pulmonary artery catheter
Intermittent thermodilution obtained through the PAC 
has been considered the gold standard for CO monitoring 
in the clinical setting since the late 1960s [16-18]. Th is 
system was widely used until the 1990s [19], when it 
started to dramatically decrease in all settings [20] 
secondary to a shift in philosophy, replacement by newer 
technologies [21], and also probably due to the wide-
spread use of transesophageal echocardiography. Most 
studies focusing on the PAC and outcome have shown no 
positive association between PAC use for fl uid manage-
ment and survival in the ICU [22-24] or in the high-risk 
surgery patient [25]. Th is conclusion combined with the 
extreme level of invasiveness, advanced level training for 
placement, and incorrect parameter interpretation have 
lead to declining use of this system [26]. However, the 
PAC still holds utility in the assessment of right 
ventricular CO, pulmonary arterial pressures [6,8], and 
mixed venous oxygen saturation monitoring [8,27]. Th e 
lack of positive impact of the PAC on patient outcome 
does not preclude its use in a selected sample of patients 
by adequately trained physicians. In addition, most new 
CO monitoring systems are still evaluated against the 
intermittent thermodilution technique in the clinical 
research practice [8].
Esophageal Doppler
Simultaneous to the decline of PAC use, development of 
less invasive hemodynamic monitoring systems started in 
the 1990s. One of the fi rst systems to be described and 
developed was the esophageal Doppler system allowing 
for non-invasive monitoring of CO [28]. Th is approach 
was described in the mid-1970s [29,30] and gained 
popularity in the 1990s after several small studies demon-
strated a positive impact on postoperative outcome in 
patients undergoing high-risk surgery [31-34]. Th e wave-
form is highly dependent on correct positioning and 
requires frequent adjustments of depth, orientation, and 
gain to optimize the signal [35] and, while esophageal 
Doppler has demonstrated utility in aiding the assess-
ment of the hemodynamic status of critically ill patients, 
this technology has been slow to be adopted [36]. Th is 
system has the most evidence regard ing improvement of 
outcome in patients under going high-risk surgery and 
therefore should be strongly con sidered in such a setting 
[37-41]. Th e National Health Service in the UK has 
recently recommended the use of this device during 
high-risk surgery [42,43].
Transpulmonary thermodilution
One of the most successful systems to be described has 
been transpulmonary thermodilution together with the 
concept of pulse contour analysis. Th is system was 
developed in the 1990s by a German company, Pulsion, 
who commercialized the PiCCO system (Pulsion, 
Munchen, Germany) [44]. Th is system, which requires 
the use of a dedicated arterial line (preferentially femoral) 
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and a central venous catheter in the superior vena cava, 
achieved reasonable acceptance in Europe but is still 
relatively unknown in the USA [36]. Recently, Edwards 
Lifesciences released a similar trans pulmonary thermo-
dilution system (Volume View; Edwards Lifesciences, 
Irvine, CA, USA) [45,46]. CO measure ments obtained 
using these systems correlate well with the PAC measure-
ments [47-50]. Th ese systems allow for continuous CO 
measurements using the calibrated pulse contour analysis 
method. While interest ing, this method remains invasive 
[51] and requires frequent recalibration when the vaso-
motor tone changes [52-55]. Today, these systems have 
gained popularity in the ICU but are still rarely used in 
the operating rooms. Additionally, few outcome studies 
have been published using this system [56] and it is not 
clear whether their benefi ts outweigh the risks associated 
with femoral line placement.
Mini-invasive and non-invasive cardiac output monitoring 
systems
More recently, mini-invasive and non-invasive hemo-
dynamic monitoring systems have been developed and 
deployed [57]. Most mini-invasive systems rely on the 
analysis of the arterial pressure waveform combined with 
the patients’ demographics [58]. Th e systems are not user 
dependent and are very easy to use (plug-and-play). Th e 
main drawback of these systems is that they are highly 
dependent on vasomotor tone and on vascular compli-
ance. Any acute change in these variables impacts the 
accuracy of these systems [54,59,60]. Th ere are limited, 
but positive, out come studies using these systems [61,62].
Finally, totally non-invasive systems have been 
developed. Bioimpedance and, more recently, bio reac-
tance systems are back in the game (bioimpedance was 
actually developed very early on, before esophageal 
Doppler, but was never quite successful in the critical 
care setting) [63-68]. Ultrasound techniques such as the 
USCOM device have been proposed in the intensive care 
and emergency department settings (USCOM, Sydney, 
Australia). More innovative, uncalibrated and non-
invasive CO measurements obtained through the analysis 
of a non-invasive arterial pressure waveform have also 
been released recently [69,70]. However, we need more 
evidence regarding the accuracy of these systems in order 
to use the output variables for clinical decision-making.
Table  1 summarizes the diff erent CO monitoring sys-
tems clinically available today.
Functional hemodynamic monitoring parameters
Apart from the technological development of CO monitor-
ing systems, most of the recent medical literature focus-
ing on hemodynamic monitoring in the critical care setting 
has focused on the so-called functional hemo dynamic 
monitoring parameters [1]. Instead of monitoring a given 
parameter, functional hemodynamic moni toring assesses 
the eff ect of a stressor on a hemodynamic parameter. For 
the assessment of preload dependence, the stress has 
been established as a fl uid challenge and the parameter 
monitored is the stroke volume or one of its surrogates 
(for example, arterial pressure) [71]. Th e eff ects of posi-
tive pressure ventilation on preload and stroke volume 
are used to detect fl uid responsiveness in mechanically 
ventilated patients under general anesthesia [5]. If 
mechanical ventilation induces prominent respira tory 
variations in stroke volume [5], systolic pressure [72-74] 
or in arterial pulse pressure (PPV) [75], the patient’s heart 
is more likely to be working on the steep portion of the 
Frank–Starling relationship and is thus preload depen-
dent. Th ese eff ects can also be assessed by measur ing the 
variability on the inferior [76,77] or superior [78] vena 
cava diameter. When these parameters cannot be used 
because one limitation is present (spon taneous venti-
lation [79], arrhythmia [80], tidal volume <7 ml/kg [81], 
open chest conditions [82]), the eff ects of passive leg 
raising on the stroke volume can be used to detect pre-
load dependence instead [83].
Monnet and colleagues have also described the eff ects 
of a tele-expiratory occlusion on arterial pulse pressure to 
predict the eff ects of volume expansion on CO [84]. Th e 
tele-expiratory occlusion test consists of a 15-second 
end-expiratory occlusion in patients under mechanical 
ventilation. Patients presenting a more than 5% increase 
in pulse pressure (systolic pressure – diastolic pressure) 
are more likely to be responders to volume expansion (in 
these patients, the increase in venous return induced by 
the decrease in intrathoracic pressure induces an increase 
in stroke volume and pulse pressure because the patient’s 
heart is working on the steep portion of the Frank–
Starling curve). Th ese maneuvers (passive leg raising and 
tele-expiratory occlusion tests) are more appropriate for 
the ICU setting while stroke volume variation, PPV or 
respiratory variations in the plethysmographic waveform 
[85] are more suited for the operating room setting.
Th ese dynamic parameters have consistently been 
shown to be superior to static parameters for the predic-
tion of fl uid responsiveness [75,86]. Moreover, some 
studies have suggested that minimization of the respira-
tory variations in the arterial pressure or in the plethys-
mo graphic waveforms could improve fl uid management 
and postoperative outcome [10,87,88]. Table  2 presents 
the various functional hemodynamic parameters avail-
able for the prediction of fl uid responsiveness as well as 
the monitors available for their display.
Evaluation of hemodynamic monitoring systems 
and how to choose among them?
Now that we have discussed the diff erent hemodynamic 
systems available, the question remains as to whether or 
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Table 1. Available cardiac output monitoring systems with their respective advantages and disadvantages
      Outcome
Technology System Invasiveness     Mechanism Advantages Disadvantages studies
Pulmonary artery 
catheter
Vigilance +++ Thermodilution Gold standard for continuous/
intermittent cardiac output 
monitoring. Allows measuring 
pulmonary pressures and mixed 
venous oxygen saturation.
No dynamic parameters 
of fl uid responsiveness, 
Provides cardiac output 
information every few 
minutes.
–
Calibrated pulse 
contour analysis
PiCCO plus ++ Transpulmonary 
thermodilution + 
pulse contour analysis
Continuous cardiac output 
monitoring. Central venous 
oxygen saturation with specifi c 
device. Good accuracy.
Remains signifi cantly 
invasive. Requires a 
specifi c femoral artery 
catheter.
0
VolumeView ++ Transpulmonary 
thermodilution + 
pulse contour analysis
Continuous cardiac output 
monitoring. Central venous 
oxygen saturation with specifi c 
device. Good accuracy.
Remains signifi cantly 
invasive. Requires a 
specifi c femoral artery 
catheter.
0
LiDCO plus + Lithium dilution Continuous cardiac output 
monitoring.
+
Uncalibrated pulse 
contour analysis
FloTrac + Pulse wave analysis Continuous cardiac output 
monitoring. Mini-invasive, self-
calibration systems.
Accuracy of cardiac 
output has been a 
concern. Sensitive to 
changes in vasomotor 
tone. Requires a specifi c 
arterial pressure sensor.
+
LiDCO Rapid + Pulse wave analysis Continuous cardiac output 
monitoring. Mini-invasive, 
self-calibration systems. Can be 
used with any arterial line and 
arterial pressure sensor.
Not enough validation 
studies.
0
Pulsiofl ex + Pulse wave analysis Continuous cardiac output 
monitoring. Mini-invasive, 
self-calibration systems. Can be 
used with any arterial line and 
arterial pressure sensor.
No validation study. 0
PRAM + Pulse wave analysis Continuous cardiac output 
monitoring. Mini-invasive, self-
calibration systems. 
Not enough validation 
studies. Requires a 
specifi c arterial kit.
0
Nexfi n 0 Non-invasive pulse 
wave analysis
Continuous cardiac output 
monitoring. Completely non-
invasive, self-calibration system.
Not enough validation 
study. Motion artifact.
0
Ultrasound Cardio Q 0+ Doppler ultrasound Less invasive then arterial-based 
systems, qualifi es for billable 
monitoring in the USA.
Requires frequent 
manipulation for proper 
position, signifi cant 
potential for user 
variability.
+++
USCOM 0 Suprasternal 
ultrasound
Non-invasive cardiac output 
measurement.
Intermittent. Operator 
dependent.
0
Bioreactance NiCOM 0 Bioreactance Non-invasive continuous 
cardiac output monitoring.
Few validation studies. 
Many limitations.
0
Endotracheal 
bioimpedance
ECOM + Bioimpedance Mini-invasive and continuous 
cardiac output monitoring.
Few validation studies. 
Requires a specifi c 
arterial kit and a specifi c 
endotracheal tube.
0
Thoracic 
bioimpedance
BioZ 0 Bioimpedance Non-invasive cardiac output 
measurement.
Many negative studies 
in the critical care 
setting.
0
0, None; 0+, very slight; + slight; ++, intermediate; +++, severe. PiCCO plus, Pulsion Medical Systems, Irving, TX, USA; VolumeView, Edwards, Irvine, CA, USA; 
LiDCO plus, LiDCO Ltd, London, UK; FloTrac, Edwards, Irvine, CA, USA; LidCO Rapid, LiDCO Ltd, London, UK; Pulsiofl ex, Pulsion Medical Systems, Irving, TX, USA; 
PRAM, Multiple Suppliers; Nexfi n, BMEye, Amsterdam, Netherlands; Cardio Q, Deltex Medical Limited, Chichester, West Sussex, UK; USCOM, Uscom, Sydney, 
Australia; NiCOM, Cheetah Medical, Tel Aviv, Israel; ECOM, ConMed, Irvine, CA, USA; BioZ, CardioDynamics, San Diego, CA, USA.
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not it matters which of them is used for the management 
of critically ill patients. Practically speaking, if we want to 
reasonably answer this question, we need to defi ne what 
we expect from these systems, to identify the setting in 
which the system is going to be used, and to evaluate 
whether or not these systems accurately achieve what we 
expect from them.
What do we expect from a hemodynamic monitoring 
system?
Th is question depends on the monitor. At the very least, 
we expect a CO monitoring system to measure CO 
accurately and we expect a fl uid responsiveness monitor 
to predict fl uid responsiveness accurately.
Evaluating the accuracy of a cardiac output monitoring 
system
Th e last two decades have seen an explosion in the 
numbers of manuscripts published aiming at evaluating 
the accuracy of a hemodynamic monitoring system to 
measure CO accurately. Dozens of manuscripts have 
tried to defi ne the methodology that should be used to 
clearly demonstrate whether or not a monitor can 
measure and track CO in the clinical setting. After more 
than a decade of research on this methodology alone, a 
consensus seems to have been reached [89-92]. Th e fi rst 
step is to evaluate the agreement between the new 
method and the gold standard (most studies still use 
intermittent thermodilution as the gold standard). For 
this purpose, Bland–Altman analysis  – originally des-
cribed to assess the agreement between two methods of 
clinical measurement  – should be used [93,94]. Th is 
analy sis provides the users with a bias and limits of agree-
ment. Unfortunately, little is known with regard to what 
is considered acceptable or not.
Th e second step is to calculate the mean percentage 
error, which is defi ned as the ratio between the range of 
the limits of agreement and the mean CO of the gold 
standard [95]. Th e idea is that narrow limits of agreement 
may mean that the system is very precise, but one must 
acknowledge that this may also only indicate the study 
was conducted in a sample of subjects presenting with 
very low CO values. According to Critchley and 
Critchley, a mean percentage error >30% should allow 
the conclusion of the new method as being inaccurate 
[95]. Once again, one must remember that this approach 
depends on the intrinsic precision of the gold standard 
[96]. Th e third step is then to test the concordance 
between the new method and the gold standard [97,98]. 
Basically, this approach aims at evaluating whether or not 
the two techniques follow the same direction when CO is 
modifi ed. For some, a weak accuracy may not be a 
problem as long as the ability to track changes is accurate. 
Th is is theoretically true since most goal-directed therapy 
protocols for fl uid management rely on relative changes 
in CO, as opposed to absolute values. However, a perfect 
trending ability together with a weak accuracy would 
essentially indicate that further calibration would solve 
the problem. Unfortunately, it is more likely that the bias 
and the limits of agreement drift over time. According to 
Critchley and colleagues, concordance <92% should be 
considered inacceptable.
Evaluating the predictive value of a functional hemodynamic 
parameter
Th e use of functional hemodynamic monitoring in the 
clinical practice is, in a way, simpler to evaluate. Th e goal 
of most functional hemodynamic monitoring parameters 
Table 2. Systems allowing for monitoring dynamic 
parameters of fl uid responsiveness
Dynamic parameter of Monitor available for
fl uid responsiveness their display
Systolic pressure variation Can be eyeballed accurately
Pulse pressure variation Cannot be eyeballed
 Philips Intellivue Monitors
 LiDCO Rapid
 LiDCO Plus
 PiCCO Plus
 PulsioFlex
 PRAM
 Nexfi n
 CNAP
 General Electric Monitors
Stroke volume variation LiDCO Rapid
 LiDCO Plus
 PiCCO Plus
 Pulsiofl ex
 PRAM
 Vigileo FloTrac
 EV1000 VolumeView
 ECOM
 BioZ
 NICOM
Pleth variability index Masimo Radical 7
Passive leg raising Demonstrated with esophageal 
 Doppler, PiCCO plus, 
 Echocardiography, NICOM, and 
 Vigileo FloTrac
PiCCO plus, Pulsion Medical Systems, Irving, TX, USA; VolumeView, Edwards, 
Irvine, CA, USA; LiDCO plus, LiDCO Ltd, London, UK; FloTrac, Edwards, Irvine, 
CA, USA; LidCO Rapid, LiDCO Ltd, London, UK; Pulsiofl ex, Pulsion Medical 
Systems, Irving, TX, USA; PRAM, Multiple Suppliers; Nexfi n, BMEye, Amsterdam, 
Netherlands; Cardio Q, Deltex Medical Limited, Chichester, West Sussex, UK; 
USCOM, Uscom, Sydney, Australia; NiCOM, Cheetah Medical, Tel Aviv, Israel; 
ECOM, ConMed, Irvine, CA, USA; BioZ, CardioDynamics, San Diego, CA, USA; 
CNAP, CNS Systems, Graz, Austria; General Electric Monitors, General Electric 
Company, Fairfi eld, Connecticut, USA; EV1000 VolumeView, Edwards, Irvine, CA, 
USA; Masimo Radical 7, Masimo, Irvine, CA, USA; esophageal Doppler, Deltex 
Medical Limited, Chichester, West Sussex, UK; Echocardiography, Multiple 
Suppliers.
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is to predict fl uid responsiveness in critically ill patients. 
For this purpose, the methodology is quite straight-
forward and has for a long time relied on the use of 
receiver operating characteristics curve analysis [99]. 
Th is analysis results in a single threshold value associated 
with a high sensitivity and specifi city for the prediction of 
fl uid responsiveness. For example, it was shown initially 
that PPV >13% in septic patients was able to predict fl uid 
responsiveness with sensitivity and specifi city >90% 
[100]. However, this methodology is very old and may 
not refl ect the actual clinical setting where such polarized 
situations do not often exist.
Signifi cant improvements have recently been made in 
the methodology used for the evaluation of a biomarker 
or diagnostic tool [101]. For instance, the gray zone 
approach has been proposed to avoid the binary 
constraints resulting from the black-or-white nature of 
the receiver operating characteristics curve that often 
does not fi t the reality of clinical or screening practice 
[101]. Th e gray zone technique proposes two cutoff 
values that constitute the borders of the gray zone. Th e 
fi rst cutoff  allows the practitioner to exclude the 
diagnosis (fl uid responsiveness in the present case) with 
near-certainty (that is, privilege sensitivity and negative 
predictive value), whereas the second cutoff  is chosen to 
indicate the value above which the selected diagnosis can 
be included with near-certainty (that is, privilege 
specifi city and positive predictive value) [101]. Inter-
mediate values included in the gray zone correspond to a 
prediction value not precise enough for a diagnostic 
decision [102]. Th is approach has recently been applied 
to test the ability of PPV to predict fl uid responsiveness 
in the perioperative setting, and it was shown, in more 
than 400 patients, that the gray zone for PPV is between 
8 and 13% and that about 25% of the patients are within 
this gray zone. If this approach was used in the ICU 
setting, the majority of patients would more likely be 
within this gray zone. Th is type of approach should help 
to better defi ne the clinical application of these functional 
hemodynamic parameters. In any case, these dynamic 
parameters have consistently been shown to be the best 
predictors of fl uid responsiveness [75,86].
Evaluating the impact on outcome
Finally, the ultimate test is to evaluate whether or not the 
use of a monitor to guide hemodynamic management 
can improve patient outcome.
Th e problem is that none of the CO monitoring 
systems available today consistently present with <30% 
mean percentage error, >92% concordance, and positive 
outcome studies. Most widely used CO monitoring sys-
tems demonstrate a mean percentage error of around 40 
to 45% [103] and most of these devices present with 
concordance <92%. Interestingly, despite these very 
disappointing results, these systems have still been tested 
in clinical outcome studies and some have demonstrated 
positive results [37,104]. Let us stress this point and be a 
little bit provocative: it is surprising to observe that a 
professional discipline such as medicine is able to 
conduct clinical studies using devices that have been 
consistently demonstrated to be inaccurate. One may 
argue that the methodology used to evaluate these 
systems (mean percentage error, concordance) is not 
appropriate and presents intrinsic limitations. However, 
would any other industry dealing with life and death 
situations accept such a shortcoming? Would an 
altimeter be used on a commercial passenger plane 
despite the fact that it has been demonstrated to be 
inaccurate according to the most commonly accepted 
standards from the Federal Aviation Administration? 
Why would we, as physicians, accept what other 
industries would clearly consider unacceptable?
Th e reason for this shortcoming is probably related to 
the fact that human physiology and physiopathology is an 
incredibly complex model. Th is explains why it is so 
diffi  cult to reliably measure physiological variables, and it 
also explains why it is so diffi  cult to make good clinical 
decisions. As a matter of fact, when dealing with complex 
situations, medical decision-making can be completely 
diff erent from one physician to the next [26]. Th is lack of 
standardization in patient management is probably one 
of the major factors infl uencing patient outcome and, 
coincidentally, one of the only factors that we can 
infl uence for the improvement of patient care. Th is has 
been beautifully demonstrated during the past 10  years 
by studies in the critical care setting focusing on protocol 
implementation and quality improvement processes 
aiming at standardizing patient care. Goal-directed 
therapy protocols or checklist implementations exemplify 
this type of approach [105-107]. Studies such as those 
conducted by Rivers and colleagues in septic patients 
showing the impact of standardizing hemodynamic 
management on survival have opened the fi eld to such 
approaches [9]. Most recently, studies have demonstrated 
that applying a simple checklist in the ICU and in the 
operating room can signifi cantly impact outcome 
[108,109]. Th ese studies are repeatedly concluding that 
decreasing the variability of care can save lives.
Concerning hemodynamic monitoring systems, the 
same approach could be applied. Clearly, despite the lack 
of precision of most CO monitoring systems available, 
some positive outcome studies have been published, 
especially in the perioperative setting with patients 
undergoing high-risk surgery. Th ese studies have shown 
that the optimization of fl uid administration based on CO 
monitoring can decrease postoperative morbidity and 
decrease the length of stay in the hospital and in the ICUs 
(Figure  1) [37,104]. Since fl uid and hemodynamic 
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management have been shown to impact postoperative 
outcome and because these two major focuses of our fi eld 
have been shown to be widely nonstandardized [110,111], 
it would then be reasonable to assume that using a CO 
monitoring system (even if not a perfect one) to guide fl uid 
administration in a standardized way in the perioperative 
period has the potential to improve post operative 
outcome. Th is approach consists of titrating fl uid, based 
on CO, until it reaches the plateau of the Frank–Starling 
relationship (Figure  1), which has been shown in several 
small clinical studies to improve patient outcome.
Th e evidence has been considered strong enough by 
the National Health Service in the UK to universally 
endorse this practice in the high-risk surgery setting 
[42,43], even though it is has created some heated discu-
ssion [112,113]. Widespread acceptance of this concept 
in other countries will probably take longer due to the 
relative infrequency of large clinical studies. Such evalu-
ations are strongly needed in the perioperative period 
[11,114]. Th is is exemplifi ed by Devereaux and colleagues 
in an editorial recently published in Anesthesiology [114]: 
‘Unlike cardiology, large clinical studies remain un-
common in perioperative medicine [115,116]. Further, 
there has been a tendency to believe the results of small 
peri operative clinical studies, especially when they 
demon strate statis tically signifi cant results. Th is position 
is supported by the fact that perioperative guideline com-
mittees recom mended β-blockers to patients undergoing 
noncardiac surgery for a decade based upon the results of 
small trials demonstrating implausibly large treatment 
eff ects’. One should also mention that large quality-
improvement programs and comparative eff ectiveness 
research studies could also be utilized as an alterna tive to 
this approach [40,117].
In addition, while functional hemodynamic parameters 
can be used as diagnostic tools to answer whether a 
patient needs fl uid or not, another approach consists of 
using these parameters to guide fl uid optimization during 
high-risk surgery [10]. As a matter of fact, the concept of 
CO maximization during surgery could be achieved by 
applying the concept of respiratory variations in arterial 
pressure or in the plethysmographic waveform minimi-
zation (Figure  2) [10]. Conducting CO maximization 
using CO monitors that have >40% mean percentage 
error [103] could theoretically be easily achieved by 
conducting PPV minimization. Th is would be a cheap 
and free-of-right way to optimize hemodynamics in the 
perioperative period. PPV minimization has been 
suggested and recently described [10,118], and the 
method could be of major importance in countries or 
institutions where the use of CO monitoring systems 
cannot be reasonably expected for all patients undergoing 
high-risk surgery but where fl uid optimization still has 
the potential to dramatically infl uence patient outcome 
[119]. Of course, it may be diffi  cult to determine the 
clinical eff ect of minimizing PPV without CO trending 
ability. However, recent studies strongly suggest that 
changes in PPV induced by volume expansion refl ect 
changes in CO with excellent sensitivity, specifi city, and a 
very narrow gray zone [120].
Figure 1. Fluid optimization concept based on stroke volume monitoring. The concept of cardiac output maximization based on fl uid 
administration and stroke volume monitoring. Small boluses of fl uid are administered intravenously (200 to 250 ml at a time) until the stroke 
volume increases by <10%.
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Which hemodynamic monitoring system? 
For which patient? When? How?
Several parameters must be considered before deciding 
which hemodynamic monitoring system should be used 
because, yes, it does eventually matter. Ideally, this 
decision should be made at the institutional level. Most 
departments throughout the world cannot aff ord to buy 
all of the market-available systems. At the same time, no 
system available today can eff ectively be used in all the 
diff erent sectors of a hospital. Depending on the patient’s 
specifi c history and course through the hospital, one 
hemodynamic monitoring system may be more appro-
priate than the other. Defi ning a set of systems available 
that will be adaptable to the various patient populations 
and clinical pathways will then be essential. Th is 
approach has been recently proposed by Alhashemi and 
colleagues (Figure  3) and has been described as an 
integrative perspective for the use of CO monitoring 
systems [3]. Th e defi ning approach takes into account the 
setting (ward, emergency depart ment, operating room, 
and ICU) as well as the integration of CO monitoring 
with or without other hemodynamic variables.
The decision should be an institutional decision and 
should integrate all clinical pathways existing within the 
institution
Institutions containing emergency departments, operat-
ing rooms, and ICUs should have non-invasive, mini-
invasive and invasive hemodynamic monitoring systems 
available to the clinicians and his or her patients. Likewise, 
when the institution performs cardiac surgery, it is still 
highly recommended to have PACs available. Th is system 
is well fi tted for patients with low ejection fraction (<30 
to 35%), moderate to severe pulmonary hypertension, 
sepsis (endocarditis), and for cardiac transplantation. If 
the patient spends more than 72 hours in the ICU after 
surgery, it is recommended to switch from the PAC to a 
transpulmonary thermodilution system. Of course, 
transesophageal echocardiography should be available in 
all institutions performing cardiac surgery. However, this 
system is not a monitoring system per se and does not 
substitute for a continuous hemo dynamic monitoring 
system.
An important consideration is that patient management 
is a continuum of care. Consequently, it is essential to 
maintain compati bility among hemodynamic monitoring 
technologies between diff erent departments within the 
institution and to favour systems able to adapt to various 
clinical pathways. For example, some patients will enter 
the hospital through the emergency department, will 
then go to the operating room, and then to the ICU. 
Ideally, the evolution in hemodynamic monitoring should 
be made available on an identical platform that will adapt 
to the changes in hemodynamic status of the patient as 
well as to the clinical scenario in these diff erent 
departments. Today, technological platforms allowing for 
a con tinuum of care from a totally non-invasive 
hemodynamic monitoring system to a mini-invasive one 
and then to an invasive one (or vice versa) are just 
emerging. For an institution to work within a given 
Figure 2. Fluid optimization concept based on minimization of dynamic parameters of fl uid responsiveness. The concept of cardiac output 
maximization based on the minimization of dynamic parameters of fl uid responsiveness. This minimization can be achieved by monitoring pulse 
pressure variation (PPV), stroke volume variation or respiratory variations in the plethysmographic waveform.
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system that would be fl exible and allow any kind of 
patient throughout the hospital to be eff ectively moni-
tored would make perfect sense. Once again, this kind 
of platform is just starting to emerge and most 
institutions still have to purchase diff erent systems, 
from diff erent companies, in order to monitor diff erent 
patients.
The systems should be paired with clearly defi ned protocols
As mentioned earlier, the only way to impact patient 
outcome is to pair the monitoring system with a 
therapeutic protocol. Th is approach has been shown to 
improve perioperative outcome in several small clinical 
studies and in some quality improvement processes 
employing the esophageal Doppler [40]. Such standardi-
zation of patient care is the only way to change current 
practice and to pragmatically and positively impact 
clinical decision-making. Standardization guidelines 
should also include the indications for hemodynamic 
monitoring and which hemodynamic monitoring system 
should be used for what patients (based on the integrative 
approach described above; Figure  3). Once again, the 
National Health Service in the UK has exemplifi ed this 
through its release of National Institute for Health and 
Clinical Excellence guidance regarding hemodynamic 
monitoring and optimization during high-risk surgery 
[42,43]. Th ese guidelines are clear and easy to apply and 
can easily be applied in any institution.
The system should be adapted to the patient
Of course, the fi nal choice of a hemodynamic monitoring 
system is patient and pathology dependent. Additionally, 
whenever possible, a non-invasive system should be used. 
However, at this stage, non-invasive systems may not be 
as reliable as invasive ones. Th ere is no doubt that non-
invasive systems will eventually take the lead in the future 
[121], but we are still contemplating the eff ective length 
of a development phase [122]. For example, non-invasive 
systems based on pulse oximeter waveform analysis have 
been shown to be able to provide useful information 
regarding fl uid responsiveness in healthy patients under 
general anesthesia [85]. However, these systems may not 
be reliable in the ICU in septic shock patients [123]. Th at 
being said: who would consider managing the hemo-
dynamic status of a septic shock patient based solely on 
the plethysmographic waveform alone? On one hand, the 
risk of using a non-invasive technique in a challenging 
setting is that it will lead to inappropriate clinical 
decisions. On the other hand, it is unacceptable to 
expand the indications for invasive monitoring when 
their risks outweigh their benefi ts. We should always 
keep this in mind when choosing the most appropriate 
hemodynamic monitor for our patients.
Conclusion
Hemodynamic monitoring and management has greatly 
improved during the past decade. Technologies have 
Figure 3. Integrative hemodynamic monitoring approach. ED, emergency department; HD, hemodynamic; OR, operating room; PAC, 
pulmonary artery catheter. Reproduced with permission from Alhashemi and colleagues [3].
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evolved from very invasive to non-invasive, and the 
philosophy has shifted from a static approach to a func-
tional approach. However, the critical care community 
still has potential to improve its ability to adopt the most 
modern standards of research methodology in order to 
more eff ectively evaluate new monitoring systems and 
their impact on patient outcome. Today, despite the huge 
enthusiasm raised by new hemodynamic monitoring 
systems, there is still a big gap between clinical research 
studies evaluating these monitors and clinical practice. A 
few studies, especially in the perioperative period, have 
shown that hemodynamic monitoring systems coupled 
with treatment protocols can improve patient outcome. 
Unfortunately these trials are small and, overall, the 
corpus of science related to this topic does not yet fi t the 
standard of clinical research methodology encountered 
in other specialties such as cardiology and oncology. 
Larger randomized trials, quality improvement pro-
cesses, and comparative eff ectiveness research studies are 
probably needed. However, some innovative professional 
societies have considered that this evidence was strong 
enough to release recommendations regarding hemo-
dynamic monitoring and management during high-risk 
surgery. For this purpose, strictly speaking, the eso pha-
geal Doppler is the device that currently presents with 
the most positive evidence.
Finally, the choice of the hemodynamic monitoring 
systems available should be a widespread institutional 
process and all departments involved should be consulted 
(emergency department, ward, ICU, and operating 
room). At the end of the day, the choice depends on the 
available expertise, on the patient population, and on the 
clinical pathways. For institutions who cannot aff ord a 
proprietary hemo dynamic monitoring system for their 
patients, fl uid optimization can be achieved eff ectively by 
monitoring respiratory variations in the arterial pressure 
or in the plethysmographic waveform depending on the 
clinical context.
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